Disclosed is an agent for preventing and treating diabetic peripheral
neuropathy including a granulocyte colony stimulating factor (G-CSF) as
an active ingredient, which is able to improve nerve conduction velocity
and pain sensitivity by regenerating blood vessels in peripheral tissues
and rehabilitating damaged nerve tissues.